ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:

Headache and Migraine

Headache and Migraine

January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.

From Alzheimer disease to Zika virus, we’ve compiled a list of this year’s most popular articles on Neurology Times.

Research from AES 2016 explored relationships between epilepsy and other neurological disorders, including Alzheimer disease, MS, stroke, and autism.

November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.

Research has linked rosacea with other neurologic conditions such as Parkinson disease and MS, but an association with migraine has been unclear.

There is no FDA-approved drug for pediatric migraine in children aged younger than 12, so treatment is consensus-based rather than evidence-based.

November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.

Pages

Subscribe to Headache and Migraine on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.